Role of microRNA-17-5p in the pathogenesis of pediatric nephrotic syndrome and related mechanisms.
- Author:
Yan-Rui ZHANG
1
;
Yi-Fei WU
;
Hui WANG
;
Xin-Mei LIN
;
Xiao-Min ZHANG
Author Information
1. Department of Pediatric Gastroenterology and Nephrology, Binzhou Medical University Hospital, Binzhou, Shandong 256603, China. kz_2yw@163.com.
- Publication Type:Journal Article
- MeSH:
Apoptosis;
Child;
Humans;
MicroRNAs;
genetics;
Nephrotic Syndrome;
genetics;
Podocytes;
Transfection
- From:
Chinese Journal of Contemporary Pediatrics
2020;22(9):958-963
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the role of microRNA-17-5p (miR-17-5p) in the pathogenesis of pediatric nephrotic syndrome (NS) and its effect on renal podocyte apoptosis via the activin A (ActA)/Smads pathway.
METHODS:An analysis was performed on 55 children with NS (NS group) who were admitted from March 2018 to March 2019. Fifty healthy children who underwent physical examination during the same period of time were enrolled as the control group. The mRNA expression of miR-17-5p in peripheral blood was measured and compared between the two groups. Human renal podocytes were transfected with antisense oligonucleotide recombinant plasmid containing miR-17-5p (inhibition group) or control vector containing nonsense random sequence (negative control group), and untreated human renal podocytes were used as the blank group. These groups were compared in terms of cell apoptosis and the mRNA and protein expression of miR-17-5p, ActA, and Smads after transfection.
RESULTS:The NS group had a significantly higher level of miR-17-5p in peripheral blood than the control group (P<0.001). Compared with the blank and negative control groups, the inhibition group had significantly lower apoptosis rate and relative mRNA expression of miR-17-5p and significantly higher relative mRNA and protein expression of ActA, Smad2, and Smad3 (P<0.001).
CONCLUSIONS:There is an increase in the content of miR-17-5p in peripheral blood in children with NS. Low expression of miR-17-5p can inhibit the apoptosis of human renal podocytes, which may be associated with the upregulation of the mRNA and protein expression of ActA, Smad2 and Smad3.
